EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Minor Proteins Involved in Neuronal Functions in Serum of Patients With Major Mental Disorders According to Proteomic Analysis

Liudmila Smirnova iD, Alexander Seregin iD, Evgeny Ermakov iD, Maria Zavialova iD, Elena Dmitrieva iD, Svetlana Novikova iD, German Simutkin iD, Elena Kornetova iD, Svetlana Ivanova iD

Alpha Psychiatry · 23.10.2026 · 27 (5)

DOI: 10.31083/ap53136 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Alpha Psychiatry, online erschienen am 23.10.2026. Verfasst von Liudmila Smirnova und 8 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Molecular Psychiatry, Mental Health Research Institute, Tomsk National Research Medical Center of the Russian Academy of Sciences, 6340…. Die Arbeit nennt 76 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Russian Science Foundation, RSF.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Schizophrenia (SCZ) and bipolar disorder (BD) share common clinical features, complicating the identification of specific peripheral biomarkers. The objective of this study was to identify biomarkers that specifically characterize different clinical forms of BD and SCZ.

Methods

A comparative proteomic analysis of serum samples from patients with SCZ and BD, as well as healthy controls, was performed using untargeted mass spectrometry to identify differentially expressed proteins. In an expanded cohort, accounting for clinical heterogeneity, the levels of six minor proteins (N-methyl-D-aspartate receptor 1 (NMDAR1), ankyrin 3 (ANK3), ankyrin repeat domain-containing protein 12 (ANKRD12), low-density lipoprotein receptor-related protein 2 (LRP2), dermcidin (DCD), and anti-NMDAR antibodies) were quantified using enzyme-linked immunosorbent assay (ELISA) and targeted mass spectrometry (for NMDAR1).

Results

Comparative serum proteomic analysis identified 440 unique proteins in healthy controls versus 221 in patients with SCZ, and 474 unique proteins in healthy controls versus 55 in patients with BD. Quantitative analysis revealed the following findings: (1) a significant increase in NMDAR1 protein levels in patients with BD experiencing a current depressive episode (BD-cDE); (2) decreased ANK3 levels in patients with BD-cDE and SCZ; (3) increased ANKRD12 protein levels in patients with SCZ characterized by predominant negative symptoms and in patients with BD-cDE; (4) decreased DCD levels in patients with SCZ in remission compared with those in the acute phase of the disease; and (5) significantly increased LRP2 levels in both BD and SCZ. Elevated anti-NMDAR antibody levels were more frequently observed in patients with BD, although absolute antibody levels were also increased in patients with acute-phase SCZ.

Conclusions

These findings suggest a common mechanism of synaptopathy involving destabilization of the ANK3-NMDAR scaffold, accompanied by a compensatory neuroprotective response in both BD and SCZ. The identified alterations in the serum protein profile may serve as potential biomarkers for the differential diagnosis of these disorders as part of multimarker diagnostic panels.

Schlagwörter

Stichwörter der Autor:innen

ANK3ANKRD12LRP2NMDAR1anti-NMDAR antibodiesbiomarkersbipolar disorderdermcidinschizophreniasynaptopathy

Autor:innen und Institutionen

  • Laboratory of Molecular Psychiatry, Mental Health Research Institute, Tomsk National Research Medical Center of the Russian Academy of Sciences, 634014 Tomsk, Russia.
  • Laboratory of Repair Enzymes, Institute of Chemical Biology and Fundamental Medicine, Siberian Branch of the Russian Academy of Sciences, 630090 Novosibirsk, Russia.
  • Advanced Mass Spectrometry Core Facility, Skolkovo Institute of Science and Technology, 121205 Moscow, Russia.
  • Laboratory of Systems Biology, Institute of Biomedical Chemistry, 119121 Moscow, Russia.
  • Affective States Department, Mental Health Research Institute, Tomsk National Research Medical Center of the Russian Academy of Sciences, 634014 Tomsk, Russia.
  • Endogenous Disorders Department, Mental Health Research Institute, Tomsk National Research Medical Center of the Russian Academy of Sciences, 634014 Tomsk, Russia.

ORCID-Profile: Liudmila Smirnova, Alexander Seregin, Evgeny Ermakov, Maria Zavialova, Elena Dmitrieva, Svetlana Novikova, German Simutkin, Elena Kornetova, Svetlana Ivanova

Förderung

  • Russian Science Foundation
  • RSF

Zitieren

APA

Smirnova, L., Seregin, A., Ermakov, E., Zavialova, M., Dmitrieva, E., Novikova, S., Simutkin, G., Kornetova, E., & Ivanova, S. (2026). Minor Proteins Involved in Neuronal Functions in Serum of Patients With Major Mental Disorders According to Proteomic Analysis. Alpha Psychiatry, 27(5). https://doi.org/10.31083/ap53136

Vancouver

Smirnova L, Seregin A, Ermakov E, Zavialova M, Dmitrieva E, Novikova S, et al. Minor Proteins Involved in Neuronal Functions in Serum of Patients With Major Mental Disorders According to Proteomic Analysis. Alpha Psychiatry. 2026;27(5). doi:10.31083/ap53136

BibTeX
@article{Smirnova2026,
  author = {Smirnova, Liudmila and Seregin, Alexander and Ermakov, Evgeny and Zavialova, Maria and Dmitrieva, Elena and Novikova, Svetlana and Simutkin, German and Kornetova, Elena and Ivanova, Svetlana},
  title = {Minor Proteins Involved in Neuronal Functions in Serum of Patients With Major Mental Disorders According to Proteomic Analysis},
  journal = {Alpha Psychiatry},
  year = {2026},
  volume = {27},
  number = {5},
  doi = {10.31083/ap53136}
}
Kostenlos starten →